---
schema_version: "secwatch.filing_event.v1"
accession: "0001372514-24-000068"
form_type: "8-K"
ticker: "KPRX"
cik: "0001372514"
company_name: "KIORA PHARMACEUTICALS INC"
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-05-31T23:57:55.402270+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Kiora appoints Walters-Hoffert to board, promotes Tosca to CFO, regains Nasdaq compliance

## Summary
- Lisa Walters-Hoffert appointed independent director and audit committee chair; Kenneth Gayron resigned.
- Melissa Tosca promoted from EVP of Finance to CFO; salary raised to $337,000, bonus target to 40%.
- CEO Brian Strem's salary increased to $569,000 (55% bonus); Chief Development Officer Daniels to $443,000 (40%).
- New non-employee director compensation: initial 1,778 stock option grant, cash retainers up to $70,000 annually.
- Regained compliance with Nasdaq minimum bid price rule (Nasdaq Listing Rule 5550(a)(2)) as of June 28, 2024.

## SEC filing metadata
- accession: 0001372514-24-000068
- form_type: 8-K
- ticker: KPRX
- cik: 0001372514
- company_name: KIORA PHARMACEUTICALS INC
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000068/0001372514-24-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000068/kprx-20240628.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001372514-24-000068
- JSON: https://secwatch.observer/filing/0001372514-24-000068.json
- Plain text: https://secwatch.observer/filing/0001372514-24-000068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.